Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

13.4%

9 terminated/withdrawn out of 67 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

18%

12 trials in Phase 3/4

Results Transparency

42%

15 of 36 completed trials have results

Key Signals

4 recruiting15 with results6 terminated

Enrollment Performance

Analytics

N/A
20(37.7%)
Phase 2
16(30.2%)
Phase 4
8(15.1%)
Phase 1
4(7.5%)
Phase 3
4(7.5%)
Early Phase 1
1(1.9%)
53Total
N/A(20)
Phase 2(16)
Phase 4(8)
Phase 1(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (67)

Showing 20 of 67 trials
NCT06087029Not ApplicableRecruiting

IMPRoving Outcomes in Vascular DisEase - Aortic Dissection

Role: collaborator

NCT04060030Phase 2Recruiting

Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism

Role: collaborator

NCT04060017Phase 2Active Not Recruiting

Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium

Role: collaborator

NCT02839915Phase 2Active Not Recruiting

Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

Role: collaborator

NCT04322734Recruiting

Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders

Role: collaborator

NCT01208662Phase 3Active Not Recruiting

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Role: collaborator

NCT05439772Phase 4Completed

Examining the Effect of Ondansetron on Bowel Prep Success

Role: lead

NCT02023333Phase 2Completed

Regorafenib in Good Performance Status Patients With Newly Diagnosed Metastatic Colorectal Adenocarcinoma

Role: collaborator

NCT00207454Phase 1Completed

Optimizing Strategies to Improve STD Partner Services

Role: collaborator

NCT04755595Phase 2Completed

Combination Facial Aesthetic Treatment in Millennials

Role: lead

NCT05796167Early Phase 1Withdrawn

Pimavanserin for Sleep in Parkinson Disease

Role: lead

NCT03654248Not ApplicableCompleted

"Let's Get Organized" in Adult Psychiatric/habilitation Care

Role: collaborator

NCT00773773Not ApplicableTerminated

Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer

Role: collaborator

NCT06030622Phase 1Recruiting

Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer

Role: lead

NCT06374407Not ApplicableNot Yet Recruiting

The MIND-GUT Digital Pilot Intervention Study

Role: collaborator

NCT05916534Not ApplicableUnknown

We Care About Brooklyn - A Digital Behavioral Intervention to Optimize Engagement in Maternal Healthcare

Role: lead

NCT06119152Not ApplicableUnknown

Digital Equity for Stroke Approach

Role: lead

NCT05288218Not ApplicableWithdrawn

Evaluation of Leak-free Bronchoscope Adapter

Role: collaborator

NCT05977400Phase 3Not Yet Recruiting

NICU Antibiotics and Outcomes (NANO) Follow-up Study

Role: collaborator

NCT03607175Phase 2Unknown

Adjunctive Treatment for Chronic Rhinosinusitis With Nasal Polyposis

Role: collaborator